7-substituted indole Mcl-1 inhibitors

Details for Australian Patent Application No. 2008242983 (hide)

Owner Abbott Laboratories

Inventors Hasvold, Lisa A.; Souers, Andrew J.; Bruncko, Milan; Madar, David; Elmore, Steven W.; Kunzer, Aaron R.; Park, Cheol-Min; Song, Xiaohong; Wang, Le; Tao, Zhi-Fu; Wang, Xilu; Wendt, Michael D.

Agent Spruson & Ferguson

Pub. Number AU-A-2008242983

PCT Pub. Number WO2008/131000

Priority 60/949,650 13.07.07 US; 60/912,038 16.04.07 US

Filing date 16 April 2008

Wipo publication date 30 October 2008

International Classifications

A61K 31/404 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 209/34 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 413/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

22 October 2009 PCT application entered the National Phase

  PCT publication WO2008/131000 Priority application(s): WO2008/131000

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008242987-Telencephalic glial-restricted cell populations and related compositions and methods

2008242981-Powered surgical system